Elisabeth Bjork - 17 Sep 2026 Form 4 Insider Report for Pharvaris N.V. (PHVS)

Reporting relationship: Director
Issuer ticker: PHVS
Reported as of: 17 Sep 2026
Net transaction value: -$1,989,409
SEC form: 4
Accepted by SEC: 21 Sep 2026, 15:20:53 UTC
Prior SEC filing: 22 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Marnus Nel, Attorney-in-Fact for Elisabeth Bjork

Key filing fact

Elisabeth Bjork filed Form 4 for Pharvaris N.V. (PHVS) on 21 Sep 2026.

Key facts

This page summarizes Elisabeth Bjork's Form 4 filing for Pharvaris N.V. (PHVS).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 21 Sep 2026, 15:20.

Change

Previous filing in this sequence was filed on 22 May 2026.
Current net transaction value: -$1,989,409.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001810406 Primary reporting owner

Bjork Elisabeth

Relationship: Director
Address: 1 CRANBERRY HILL SUITE 400, LEXINGTON
Signature: /s/ Marnus Nel, Attorney-in-Fact for Elisabeth Bjork
Signature date: 21 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PHVS transaction

Common Stock

Options Exercise

Transaction value
Shares: +35,000
Change %: +231%
Price: $14.39^*
Shares after: 50,167
Date: 17 Sep 2026
Ownership: Direct

PHVS transaction

Common Stock

Options Exercise

Transaction value
Shares: +17,500
Change %: +35%
Price: $18.14^*
Shares after: 67,667
Date: 17 Sep 2026
Ownership: Direct

PHVS transaction

Common Stock

Sale

Transaction value: $1,989,409
Shares: -52,500
Change %: -78%
Price: $37.89
Shares after: 15,167
Date: 17 Sep 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHVS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -35,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 17 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,000
Exercise price: $14.39
Footnotes: F2

PHVS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -17,500
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 17 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,500
Exercise price: $18.14
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $37.62 to $38.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Footnote F2

25% of the option vested on January 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter.

Footnote F3

25% of the option vested on April 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter.